Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 2.2024
Journal of the National Comprehensive Cancer Network · 2024-04 · 22 (3) · 175-204
DOI: 10.6004/jnccn.2024.0018 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the National Comprehensive Cancer Network, 2024-04. Verfasst von William G Wierda und 35 weiteren Autor:innen. Beteiligte Einrichtung: 1The University of Texas MD Anderson Cancer Center. Hauptthemen laut MEDLINE: Leukemia, Lymphocytic, Chronic, B-Cell. Die Arbeit wurde bisher 74-mal zitiert (Crossref) und nennt 194 Literaturangaben.
Abstract (Originalsprache)
Chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL) are essentially different manifestations of the same disease that are similarly managed. A number of molecular and cytogenetic variables with prognostic implications have been identified. Undetectable minimal residual disease at the end of treatment with chemoimmunotherapy or venetoclax-based combination regimens is an independent predictor of improved survival among patients with previously untreated or relapsed/refractory CLL/SLL. The selection of treatment is based on the disease stage, presence or absence of del(17p) or TP53 mutation, immunoglobulin heavy chain variable region mutation status, patient age, performance status, comorbid conditions, and the agent’s toxicity profile. This manuscript discusses the recommendations outlined in the NCCN Guidelines for the diagnosis and management of patients with CLL/SLL.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- 1The University of Texas MD Anderson Cancer Center.
- 2Dana-Farber/Brigham and Women's Cancer Center.
- 3Mass General Cancer Center.
- 4UT Southwestern Simmons Comprehensive Cancer Center.
- 5Yale Cancer Center/Smilow Cancer Hospital.
- 6Fred & Pamela Buffett Cancer Center.
Zitieren
APA
Wierda, W. G., Brown, J., Abramson, J. S., Awan, F., Bilgrami, S. F., Bociek, G., Brander, D., Cortese, M., Cripe, L., Davis, R. S., Eradat, H., Fakhri, B., Fletcher, C. D., Gaballa, S., Hamid, M. S., Hill, B., Kaesberg, P., Kahl, B., Kamdar, M., …, & Dwyer, M. (2024). Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 2.2024. Journal of the National Comprehensive Cancer Network, 22(3), 175-204. https://doi.org/10.6004/jnccn.2024.0018
Vancouver
Wierda WG, Brown J, Abramson JS, Awan F, Bilgrami SF, Bociek G, et al. Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 2.2024. Journal of the National Comprehensive Cancer Network. 2024;22(3):175-204. doi:10.6004/jnccn.2024.0018
BibTeX
@article{Wierda2024,
author = {Wierda, William G and Brown, Jennifer and Abramson, Jeremy S and Awan, Farrukh and Bilgrami, Syed F and Bociek, Greg and Brander, Danielle and Cortese, Matthew and Cripe, Larry and Davis, Randall S and Eradat, Herbert and Fakhri, Bita and Fletcher, Christopher D and Gaballa, Sameh and Hamid, Muhammad Saad and Hill, Brian and Kaesberg, Paul and Kahl, Brad and Kamdar, Manali and Kipps, Thomas J and Ma, Shuo and Mosse, Claudio and Nakhoda, Shazia and Parikh, Sameer and Schorr, Andrew and Schuster, Stephen and Seshadri, Madhav and Siddiqi, Tanya and Stephens, Deborah M and Thompson, Meghan and Ujjani, Chaitra and Valdez, Riccardo and Wagner-Johnston, Nina and Woyach, Jennifer A and Sundar, Hema and Dwyer, Mary},
title = {Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 2.2024},
journal = {Journal of the National Comprehensive Cancer Network},
year = {2024},
volume = {22},
number = {3},
pages = {175--204},
doi = {10.6004/jnccn.2024.0018}
}
EUVIMED